Labad, Jesseca D.

HRN: 13-18-82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2025
MUPIROCIN 2%, 15G (TUBE)
08/28/2025
08/28/2025
TOPICAL
1ml
OD
SP LTCS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines